Renagel
Product Images NDC 68151-4295

4 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Renagel (NDC 68151-4295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl681514295)

Label Image (Lbl681514295)
Label for RENAGEL sevelamer hydrochloride 400 mg tablets manufactured by Genzyme, with NDC 58468-0020-01. The label includes a barcode, lot number LOT B6588B01, expiration date 12/17, and indicates prescription use only.*
FDA Label Image

Figure 1 (Renagel 01)

Figure 1 (Renagel 01)
Chemical structure diagram showing the polymer components and hydrochloride groups of the active ingredient in RENAGEL. The structure illustrates repeating units with NH2·nHCl groups and side chains containing NH and OH groups, representing the molecular make-up of the compound used in this medication.*
FDA Label Image

Figure 2 (Renagel 02)

Figure 2 (Renagel 02)
A line graph depicting the percentage of patients with a reduction greater than a specified threshold relative to the reduction in serum phosphorus levels (mg/dL). Two lines compare the effects of Sevelamer Hydrochloride and an Active Control, showing changes from baseline including increased or worsened phosphorus and improved reduction.*
FDA Label Image

Figure 3 (Renagel 03)

Figure 3 (Renagel 03)
A line graph showing phosphorus change from baseline over 52 study weeks comparing Sevelamer Hydrochloride and an active control. The Y-axis measures phosphorus change from baseline, ranging approximately from -5 to 2, and the X-axis represents study weeks from 0 to 52. Sevelamer Hydrochloride is depicted with a black line and filled circles, showing greater phosphorus reduction compared to the active control, represented by a red line with open squares.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.